CRISPR Therapeutics Shareholders Equity (Quarterly)

CRISPR Therapeutics AG (CRSP)

43.85

-0.50 (-1.13%) USD | NASDAQ | Mar 28, 16:00

44.15

+0.30 (+0.68%) After-Hours: 20:00

Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2022	1.875B
September 30, 2022	1.954B
June 30, 2022	2.091B
March 31, 2022	2.245B
December 31, 2021	2.399B
September 30, 2021	2.513B
June 30, 2021	2.604B
March 31, 2021	1.805B
December 31, 2020	1.664B
September 30, 2020	1.343B
June 30, 2020	910.67M
March 31, 2020	886.10M
December 31, 2019	939.42M
September 30, 2019	591.88M

Date	Value
June 30, 2019	367.68M
March 31, 2019	379.81M
December 31, 2018	392.20M
September 30, 2018	417.31M
June 30, 2018	265.15M
March 31, 2018	290.34M
December 31, 2017	187.83M
September 30, 2017	178.96M
June 30, 2017	197.80M
March 31, 2017	215.18M
December 31, 2016	232.85M
September 30, 2016	-62.48M
June 30, 2016	135.34M
December 31, 2015	-29.10M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

265.15M

Minimum

Jun 2018

2.604B

Maximum

Jun 2021

1.297B

Average

1.141B

Median

Shareholders Equity (Quarterly) Benchmarks

Vertex Pharmaceuticals Inc	13.91B
Intellia Therapeutics Inc	1.236B
Beam Therapeutics Inc	733.47M
Moderna Inc	19.12B
Editas Medicine Inc	360.68M

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly)	2.243B
Total Liabilities (Quarterly)	367.58M
Current Ratio	15.30